Ad is loading...
ACHL
Price
$1.07
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
102 days until earnings call
SQZB
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Nov 19 closing price
Ad is loading...

ACHL vs SQZB

Header iconACHL vs SQZB Comparison
Open Charts ACHL vs SQZBBanner chart's image
Achilles Therapeutics
Price$1.07
Change-$0.00 (-0.00%)
Volume$96.52K
CapitalizationN/A
SQZ Biotechnologies
Price$0.02
Change-$0.00 (-0.00%)
Volume$900
CapitalizationN/A
ACHL vs SQZB Comparison Chart
Loading...
ACHL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ACHL vs. SQZB commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHL is a Hold and SQZB is a Buy.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (ACHL: $1.07 vs. SQZB: $0.03)
Brand notoriety: ACHL and SQZB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHL: 11% vs. SQZB: 6%
Market capitalization -- ACHL: $45.69M vs. SQZB: $781.51K
ACHL [@Biotechnology] is valued at $45.69M. SQZB’s [@Biotechnology] market capitalization is $781.51K. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHL’s FA Score shows that 1 FA rating(s) are green whileSQZB’s FA Score has 1 green FA rating(s).

  • ACHL’s FA Score: 1 green, 4 red.
  • SQZB’s FA Score: 1 green, 4 red.
According to our system of comparison, ACHL is a better buy in the long-term than SQZB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHL’s TA Score shows that 3 TA indicator(s) are bullish.

  • ACHL’s TA Score: 3 bullish, 5 bearish.

Price Growth

ACHL (@Biotechnology) experienced а 0.00% price change this week, while SQZB (@Biotechnology) price change was +15.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.97%, and the average quarterly price growth was +4.04%.

Reported Earning Dates

ACHL is expected to report earnings on Mar 04, 2025.

SQZB is expected to report earnings on Nov 21, 2024.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACHL($45.3M) has a higher market cap than SQZB($826K). SQZB YTD gains are higher at: 33.166 vs. ACHL (20.360).
ACHLSQZBACHL / SQZB
Capitalization45.3M826K5,484%
EBITDA-67.33MN/A-
Gain YTD20.36033.16661%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash86.1MN/A-
Total Debt3.62MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ACHL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Ad is loading...
ACHL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RFL2.030.08
+4.10%
Rafael Holdings
LINC15.600.22
+1.43%
Lincoln Educational Services Corp
F10.800.07
+0.65%
Ford Motor Company
KBH77.79-0.18
-0.23%
KB Home
AMRC26.13-0.62
-2.32%
Ameresco

ACHL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHL has been loosely correlated with SCNI. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHL jumps, then SCNI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHL
1D Price
Change %
ACHL100%
N/A
SCNI - ACHL
45%
Loosely correlated
+3.07%
SNPX - ACHL
43%
Loosely correlated
-3.24%
MDGL - ACHL
34%
Loosely correlated
+3.83%
EWTX - ACHL
32%
Poorly correlated
+0.09%
CYTK - ACHL
32%
Poorly correlated
-4.39%
More

SQZB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SQZB has been loosely correlated with MDGL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if SQZB jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SQZB
1D Price
Change %
SQZB100%
+15.22%
MDGL - SQZB
33%
Loosely correlated
+3.83%
ARRY - SQZB
33%
Loosely correlated
-0.63%
AXON - SQZB
33%
Poorly correlated
+3.52%
MIST - SQZB
31%
Poorly correlated
-0.54%
ACHL - SQZB
30%
Poorly correlated
N/A
More